Related references
Note: Only part of the references are listed.Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
Siobhan Conroy et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment
Tiffany T. Liu et al.
NEURO-ONCOLOGY (2017)
TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study
Janet E. Murphy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer
Alex R. Menter et al.
CLINICAL LUNG CANCER (2017)
Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients
Antoine Kourilsky et al.
JOURNAL OF NEUROLOGY (2016)
Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
Rana R. McKay et al.
CLINICAL CANCER RESEARCH (2015)
Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma
E. Januel et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
Christine Lu-Emerson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
Antonio Facciorusso et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma
Victor A. Levin et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature
Giuseppe Lombardi et al.
ANTI-CANCER DRUGS (2013)
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T. Batchelor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combining two strategies to improve perfusion and drug delivery in solid tumors
Triantafyllos Stylianopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan et al.
NATURE COMMUNICATIONS (2013)
Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients
A. F. Carpentier et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts
Veronique Lorgis et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
Benjamin Diop-Frimpong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The renin-angiotensin system and cancer: old dog, new tricks
Amee J. George et al.
NATURE REVIEWS CANCER (2010)
Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma
O Arrieta et al.
BRITISH JOURNAL OF CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
E Rivera et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
